Founded in 1998, C-Change assembled key cancer leaders from the three sectors — private, public, and not-for-profit — and from across the cancer continuum — prevention, early detection, treatment and quality of life, to work on the wicked problems of our time. The mission was to eliminate cancer as a major public health problem at the earliest possible time by leveraging the expertise and resources of a unique multi-sector membership.
After 19 years of service to the community, C-Change will officially close April 30, 2017. The Board of Directors, supported by our Co-Chairs and Founders, President H. W. Bush, Barbara Bush and Coach Mike Krzyzewski, unanimously decided that our original purpose, and one of the greatest challenges to achieve progress (collaboration) had been achieved. C-Change will share remaining assets (financial and intellectual) to support the work of the CEO Roundtable on Cancer. For more about the legacy of C-Change, please review the special booklet created to celebrate the 15th Anniversary.
If you are interested in accessing publications or reports published by C-Change, please review the publications listed below.
Publications & Reports
Communications Initiative (messages)
The public receives mixed messages about cancer and ways to reduce their risk for disease. C-Change, in partnership with the Ad Council, developed a series of consumer-tested messages highlighting ways to “Reduce Your Risk of Cancer” through prevention and early detection. The messages focus on four key modifiable risk factors for cancer: smoking/tobacco use, nutrition, exercise, and screening.
Making the Business Case for Prevention
Employers are uniquely positioned to provide and promote health — and to realize a return on their investment. C-Change, in partnership with the Ad Council, developed materials that document the rationale, implementation strategies, and return on investment for employers to provide and promote medically-proven cancer prevention and early detection services through their employee health insurance policies.
Cancer Core Competency Initiative
The demand for cancer services is projected to exceed the supply of cancer health professionals — threatening access and quality across the continuum of research and care. In an effort to complement the workforce development efforts of other cancer organizations, C-Change developed the Cancer Core Competency Initiative to improve the cancer knowledge and skills of non-oncology health professionals. An expert panel developed cancer competency standards and implementation tools that have proven useful and flexible among diverse disciplines, within different types of organizations, and across various cancer topics.
- Misery Finds Collaborative Company: Addressing the Health Workforce Shortage through a Multidisciplinary Approach
- Addressing the Cancer Workforce Crisis Using a Competency-Based Approach with Non-Oncology Health Professionals
- A Competency-Based Approach To Expanding the Cancer Care Workforce: Proof of Concept
- A Competency-Based Approach to Expanding the Cancer Care Workforce
- Strengthening the Non-Oncology Health Workforce Through a Competency-based Approach
- A Competency-Based Approach to Expanding the Cancer Care Workforce Part III: Improving Cancer Pain and Palliative Care Competency
- C-Change Cancer Core Competency Initiative General Logic Model Example
- C-Change Complete Listing of Cancer Core Competency Standards
Careers in Cancer Speaker's Kit
Nearly all professional disciplines that play a role in the delivery of cancer care are experiencing a shortage. As a part of its efforts to bolster the health workforce, C-Change developed the Careers in Cancer Speaker’s Kit. These presentation tools inspire high school and college students to make a difference through a career in the field of cancer and provide profiles of several career pathways.
Cancer Screening: Payer Cost/Benefit Thru Employee Benefits Program
While strong evidence describes the health benefits of cancer prevention and early detection, little evidence describes the return on investment to employers who provide these services through their health insurance policies. C-Change and the American Cancer Society commissioned Milliman, a consulting and actuarial firm, to analyze the costs and benefits of cancer screening and early detection to employee benefit programs. This landmark paper also describes examples of how employers and insurers can use employee benefit programs effectively to address cancer. Focused on breast, cervical, and colorectal cancers, the study found that cancer prevention and early detection is low cost; the cost of people with cancer is high; and that investment in prevention and early detection makes financial sense.
Cancer Surveillance and Information Summit II
Better integrating cancer surveillance systems and health information systems has the potential to improve both research and practice. In February 2008, C-Change convened multi-sector leaders at the Cancer Surveillance and Information Summit II to explore ways to further linkages between these important systems.
Access to Care Guidance Document
Numerous barriers interfere with access to cancer care such as limited financial resources, insurance, transportation, availability of providers and services, as well as language and culture. C-Change commissioned Strategic Health Concepts, a consulting firm, to author the Access to Care Guidance Document to help Comprehensive Cancer Control (CCC) Coalitions systematically address issues related to assuring timely access to cancer prevention and early detection services and associated follow-up care and treatment services.
Accelerating Research: Removing Barriers to Larger National Investment in Chemoprevention Drug Development
In addition to reducing cancer risk through primary prevention and early detection, preventing cancer and cancer recurrence through drug therapy is an increasingly promising field.
Clinical Trials Guidance Documents
Clinical trials are a vital part of cancer research and cancer treatment in the U.S. However, several policy and practice barriers hamper patient access to and enrollment in clinical trials. C-Change and the Coalition of Cancer Cooperative Groups commissioned The Lewin Group to develop two guidance documents to address these issues:
State, American Indian/Alaska Native and Pacific Island Jurisdictions Comprehensive Cancer Control Policy & Practice Summits Reports
Comprehensive Cancer Control coalitions (CCCs) exist in each State and in many Tribes, Territories, and Pacific Island Jurisdictions to reduce the burden of cancer in the unique populations they serve. The CCC National Partnership, of which C-Change is a member, hosted a series of summit meetings to foster advances in cancer control practice and policy as part of their ongoing effort to provide training and technical assistance in support of CCC progress.
The Societal and Economic Impact of Cancer Health Disparities
This case statement describes the societal & economic impact [e.g., Years of Potential Life Lost, etc.] of current cancer morbidity and mortality rates among minority and other disparate populations in the hope that the detailed information and data will help spur a national effort to address cancer health disparities.
Engaging Businesses In Comprehensive Cancer Control Coalitions: The Value Proposition For Comprehensive Cancer Control Toolkit
Leaders from all sectors can play an important role in comprehensive cancer control. Business leaders with untapped expertise and resources are often underrepresented in comprehensive cancer control (CCC) coalitions. This Toolkit is designed to support coalitions in analyzing their current membership and identifying and engaging new members from the business (for-profit) community.